Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-20

Clinical Trial Update: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study comparing subcutaneously injected prandial insulins to insulin lispro alone in adults with Type 2 diabetes mellitus; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prandial insulin (experimental) (prandial insulin)
  • insulin lispro (insulin lispro)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Diabetes Mellitus, Type II | Phase 2 | Status: COMPLETED | Results posted: 2014-08-20